A study by Martha Slattery and colleagues in 2018 showed that the NF-κB signaling pathway is dysregulated in CRC, as are p53 and Wnt/β-catenin signaling [172, 222]. The gene discussed is NFKB1; the disease is colorectal carcinoma.